NCT05690529

Brief Summary

Determine echocardiographic predictors of atrial fibrillation recurrence post radiofrequency Ablation and evaluate markers of low voltage areas on 3D mapping.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Mar 2022

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 29, 2022

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

January 10, 2023

Completed
9 days until next milestone

First Posted

Study publicly available on registry

January 19, 2023

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 31, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 31, 2024

Completed
Last Updated

January 19, 2023

Status Verified

January 1, 2023

Enrollment Period

2.2 years

First QC Date

January 10, 2023

Last Update Submit

January 10, 2023

Conditions

Atrial Fibrillation

Keywords

Atrial fibrillationRadiofrequency ablation

Outcome Measures

Primary Outcomes (1)

  • Recurrence

    1 year

Secondary Outcomes (1)

  • Low voltage areas

    At procedure

Study Arms (2)

No recurrence

No recurrence of AF

Procedure: Ablation

Recurrence

Recurrence of AF

Procedure: Ablation

Interventions

AblationPROCEDURE

Radiofrequency AF ablatoon

No recurrenceRecurrence

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients undergoing radiofrequency AF ablation guided by 3D mapping

You may qualify if:

  • paroxysmal or persistent ablation

You may not qualify if:

  • previous AF ablation
  • previous left atrial ablation
  • refusal to give informed consent
  • congenital cradiomiopathy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Centro Hospitalar e Universitário de Coimbra

Coimbra, Portugal

RECRUITING

MeSH Terms

Conditions

Atrial Fibrillation

Condition Hierarchy (Ancestors)

Arrhythmias, CardiacHeart DiseasesCardiovascular DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Central Study Contacts

Diogo Fernandes

CONTACT

23940040011750@chuc.min-saude.pt

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
1 Year
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dr.

Study Record Dates

First Submitted

January 10, 2023

First Posted

January 19, 2023

Study Start

March 29, 2022

Primary Completion

May 31, 2024

Study Completion

May 31, 2024

Last Updated

January 19, 2023

Record last verified: 2023-01

Locations

PT(1)